Forte Biosciences Statistics

Total Valuation

FBRX has a market cap or net worth of $21.50 million. The enterprise value is -$8.94 million.

Market Cap	21.50M
Enterprise Value	-8.94M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, after market close.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

FBRX has 36.44 million shares outstanding. The number of shares has increased by 119.37% in one year.

Shares Outstanding	36.44M
Shares Change (YoY)	+119.37%
Shares Change (QoQ)	+45.97%
Owned by Insiders (%)	10.91%
Owned by Institutions (%)	55.78%
Float	22.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.75
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.45, with zero debt.

Current Ratio	9.45
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -99.40% and return on invested capital (ROIC) is -116.56%.

Return on Equity (ROE)	-99.40%
Return on Assets (ROA)	-85.70%
Return on Capital (ROIC)	-116.56%
Revenue Per Employee	n/a
Profits Per Employee	-$3.57M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.87% in the last 52 weeks. The beta is 1.48, so FBRX's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	-41.87%
50-Day Moving Average	0.58
200-Day Moving Average	0.63
Relative Strength Index (RSI)	53.80
Average Volume (20 Days)	15,916

Short Selling Information

The latest short interest is 20,321, so 0.06% of the outstanding shares have been sold short.

Short Interest	20,321
Short Previous Month	17,140
Short % of Shares Out	0.06%
Short % of Float	0.09%
Short Ratio (days to cover)	0.81

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-33.44M
Pretax Income	-32.14M
Net Income	-32.14M
EBITDA	-32.13M
EBIT	-32.14M
Earnings Per Share (EPS)	-$0.88

Full Income Statement

Balance Sheet

The company has $30.44 million in cash and no debt, giving a net cash position of $30.44 million or $0.84 per share.

Cash & Cash Equivalents	30.44M
Total Debt	n/a
Net Cash	30.44M
Net Cash Per Share	$0.84
Equity (Book Value)	28.69M
Book Value Per Share	0.79
Working Capital	28.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.17 million and capital expenditures -$94,000, giving a free cash flow of -$30.26 million.

Operating Cash Flow	-30.17M
Capital Expenditures	-94,000
Free Cash Flow	-30.26M
FCF Per Share	-$0.66

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-119.37%
Shareholder Yield	-119.37%
Earnings Yield	-149.50%
FCF Yield	-140.75%

Analyst Forecast

The average price target for FBRX is $3.38, which is 472.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.38
Price Target Difference	472.88%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-14.23%

Stock Forecasts

Stock Splits

The last stock split was on June 16, 2020. It was a reverse split with a ratio of 1:15.

Last Split Date	Jun 16, 2020
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1